Healthy adult
REGISTRATION CLOSED
Despite the efforts made through information campaigns by various organizations and actors in recent years 1 , the lack of knowledge and awareness about the importance of vaccines in the adult population remains a significant challenge, posing a first barrier 1 . Furthermore, these prevention measures require significant effort and resources from the different actors in the health system at various levels of care, which represents a second barrier.
Therefore, it is especially interesting to explore the multiplier effect that additional efficiency measures applied through technological solutions could have on the entire current vaccination circuit for healthy adults 2 .
"Innovation Call – Healthy Adult"
29 solutions that harness the power of technology
to drive prevention.
Because arriving early makes a difference.
Challenges
Challenges
How to improve vaccination coverage in adults
How can we optimize vaccination rates in healthy adults while maximizing the impact of new technologies?
Challenge
How can we optimize vaccination rates in healthy adults while maximizing the impact of new technologies?
Your solution could be the answer
Can your solution help us respond to these challenges?
Use cases
Can your solution help us respond to these challenges?
REGISTRATION CLOSED¿Qué herramientas pueden optimizar la captación de la población elegible según las recomendaciones en los diferentes ámbitos del circuito asistencial?
¿Qué soluciones podemos implementar para aumentar la adherencia a los calendarios vacunales en la población adulta?
Cómo podemos utilizar tecnologías digitales para optimizar el seguimiento y recordatorio de las vacunas en adultos?
PARTICIPANTS
Who can participate?
Startups, research centers, universities, spin-offs, and any entity or organization, national or international, that is the exclusive owner of innovative technologies with the potential to solve challenges.
Take on the challenge and solve one or more of the proposed use cases.
They are considered medical devices and have the CE and MDR marking within the regulatory framework.
They must be protected or in the process of obtaining intellectual property rights. They must be transferable or licensable.
Have high growth potential and scalability.
*Includes having at least a TRL 6 (system or subsystem model or prototype demonstration in a relevant environment)
Cómo participar
Candidate Kit
Please read the candidate kit carefully and review the registration form.
Prepare the information
Complete the registration form and verify all information.
Registration form
The call is currently closed.
1. Ibáñez, M., & Punzano, D. (2025, February 18). Awareness, interoperability, and equity: the keys to the future of vaccines. Medical Editorial. https://www.redaccionmedica.com/secciones/sanidad-hoy/concienciacion-interoperabilidad-y-equidad-claves-del-futuro-en-vacunas-4651
2. Ministry of Health, Consumer Affairs and Social Welfare – Campaigns – European Vaccination Week [Internet]. Gob.es. [Last accessed: March 2025]. Available at: https://www.sanidad.gob.es/campannas/campanas16/vacunacionBeneficios.htm 5